Advertisement

Topics

Dynavax wins US FDA approval for first two-dose HBV vaccine

10:42 EST 10 Nov 2017 | thePharmaLetter

Shares in California's Dynavax Technologies are up about 4% in New York after the company announced its…

Original Article: Dynavax wins US FDA approval for first two-dose HBV vaccine

NEXT ARTICLE

More From BioPortfolio on "Dynavax wins US FDA approval for first two-dose HBV vaccine"

Advertisement
Quick Search
Advertisement
Advertisement